Blood Medicine: Blowing the Whistle on One of the Deadliest Prescription Drugs Ever

Overview

Blood Feud rivals A Civil Action for best non-fiction book of the past twenty years.” — John Lescroart, New York Times bestselling author of Damage

Procrit seemed like a biotech miracle, promising a golden age in medical care. Developed in the 1980s by Amgen and licensed to the pharmaceutical giant, Johnson & Johnson, the drug (AKA Epogen and Aranesp) soon generated billions in annual revenue—and still does.  In 2012, world famous cyclist, Olympian, and Tour de France ...

See more details below
Paperback
$13.73
BN.com price
(Save 19%)$17.00 List Price

Pick Up In Store

Reserve and pick up in 60 minutes at your local store

Other sellers (Paperback)
  • All (32) from $1.99   
  • New (17) from $1.99   
  • Used (15) from $1.99   

Overview

Blood Feud rivals A Civil Action for best non-fiction book of the past twenty years.” — John Lescroart, New York Times bestselling author of Damage

Procrit seemed like a biotech miracle, promising a golden age in medical care. Developed in the 1980s by Amgen and licensed to the pharmaceutical giant, Johnson & Johnson, the drug (AKA Epogen and Aranesp) soon generated billions in annual revenue—and still does.  In 2012, world famous cyclist, Olympian, and Tour de France champion Lance Armstrong was banned from professional cycling on doping charges for using EPO (the blanket name for the drugs Procrit and Epogen), resulting in a global controversy about abuse, big pharmaceutical companies, and the lies and inaccuracies concerning performance-enhancing drugs.

Mark Duxbury was a J&J salesman who once believed in the blood-booster, setting record sales and winning company awards. Then Duxbury started to learn unsavory truths about Procrit and J&J’s business practices. He was fired and filed a whistleblower suit to warn the public.

When Jan Schlichtman (A Civil Action) learned of Duxbury’s crusade, he signed on. Now, he’s fighting on behalf of cancer patients and for every American who trusts Big Pharma with his life.

Read More Show Less

What People Are Saying

From the Publisher
“A page-turner, this alarming chronicle of profit seeking in American medicine will appeal to all who are invested in the health care they receive or the drugs they’re prescribed.” —Library Journal
Read More Show Less

Product Details

  • ISBN-13: 9780452298507
  • Publisher: Penguin Group (USA)
  • Publication date: 8/28/2012
  • Pages: 448
  • Sales rank: 948,022
  • Product dimensions: 5.30 (w) x 7.90 (h) x 1.10 (d)

Meet the Author

Kathleen Sharp is a journalist whose work has appeared in The New York Times Magazine, Parade, Elle, and Fortune, among many other publications; she has won six awards from the Society of Professional Journalists, among other honors. She lives in Santa Barbara, California.

Read More Show Less

Table of Contents

Prologue 1

Part I

1 Meet and Greet 7

2 The Deal 24

3 Medicine Road 41

4 Raise the Stakes 54

5 The Cancer Indication 66

6 Chosen One 82

Part II

7 The Deposition 101

8 On the Border 112

9 Blues 129

10 Quality of Life 148

11 Gaslighting 164

12 The Overdose Plan 177

Part III

13 The Millionaires' Club 197

14 "Strength for Living" 219

15 Code Mistress 234

16 The Arbitrator 257

17 For the King 273

18 Black Ops 289

19 The Eleventh Hour 303

Part IV

20 Twice Saved 319

21 Miracle-Gro 335

22 Brothers 355

23 As the World Spins 369

24 The Burden 384

Notes 401

Acknowledgments 423

Index 425

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)